Thromboembolism during immune checkpoint inhibitor therapy: frequency and risk factors
Abstract Background Thromboembolism (TE) is a well-known complication during chemotherapy in cancer patients. However, the risk of TE associated with immune checkpoint inhibitors (ICIs) is unknown. This study was performed to investigate the incidence of TE and associated risk factors in patients tr...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer
2024-10-01
|
| Seria: | Discover Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1007/s12672-024-01416-z |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|